These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 1511480)

  • 1. In vitro and in vivo suppression of interleukin-2-activated killer cell activity by chimeric proteins between interleukin-2 and Pseudomonas exotoxin.
    Puri RK; FitzGerald D; Leland P; Kozak RW; Pastan I
    Cell Immunol; 1992 Sep; 143(2):324-34. PubMed ID: 1511480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A chimeric protein comprised of IL-4 and Pseudomonas exotoxin is cytotoxic for activated human lymphocytes.
    Puri RK; Mehrotra PT; Leland P; Kreitman RJ; Siegel JP; Pastan I
    J Immunol; 1994 Apr; 152(7):3693-700. PubMed ID: 8144944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effect of Nocardia rubra cell wall skeleton and recombinant interleukin 2 for in vivo induction of lymphokine-activated killer cells.
    Miyazaki K; Yasumoto K; Yano T; Matsuzaki G; Sugimachi K; Nomoto K
    Cancer Res; 1991 Oct; 51(19):5261-5. PubMed ID: 1833049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased cytotoxicity of interleukin 2-pseudomonas exotoxin (IL2-PE) chimeric proteins containing a targeting signal for lysosomal membranes.
    Fishman A; Bar-Kana Y; Steinberger I; Lorberboum-Galski H
    Biochemistry; 1994 May; 33(20):6235-43. PubMed ID: 8193138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Tac(Fab)-PE40, a recombinant double-chain immunotoxin which kills interleukin-2-receptor-bearing cells and induces complete remission in an in vivo tumor model.
    Kreitman RJ; Chang CN; Hudson DV; Queen C; Bailon P; Pastan I
    Int J Cancer; 1994 Jun; 57(6):856-64. PubMed ID: 8206679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic activity of a recombinant fusion protein between interleukin 4 and Pseudomonas exotoxin.
    Ogata M; Chaudhary VK; FitzGerald DJ; Pastan I
    Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4215-9. PubMed ID: 2657746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxicity of IL6-PE40 and derivatives on tumor cells expressing a range of interleukin 6 receptor levels.
    Siegall CB; FitzGerald DJ; Pastan I
    J Biol Chem; 1990 Sep; 265(27):16318-23. PubMed ID: 2118904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-2-PE40 prevents the development of tumors in mice injected with IL-2 receptor expressing EL4 transfectant tumor cells.
    Kozak RW; Lorberboum-Galski H; Jones L; Puri RK; Willingham MC; Malek T; Fitzgerald DJ; Waldmann TA; Pastan I
    J Immunol; 1990 Oct; 145(8):2766-71. PubMed ID: 2212661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL2-PE664Glu, a new chimeric protein cytotoxic to human-activated T lymphocytes.
    Lorberboum-Galski H; Garsia RJ; Gately M; Brown PS; Clark RE; Waldmann TA; Chaudhary VK; FitzGerald DJ; Pastan I
    J Biol Chem; 1990 Sep; 265(27):16311-7. PubMed ID: 1975810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentative effect of Nocardia rubra cell-wall skeleton on the induction of human lymphokine-activated killer (LAK) cells by the production of LAK cell helper factor(s).
    Shirasaka T; Kawase I; Okada M; Kitahara M; Ikeda T; Komuta K; Hosoe S; Yokota S; Masuno T; Kishimoto S
    Cancer Immunol Immunother; 1989; 30(4):195-204. PubMed ID: 2598189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic activity of an interleukin 6-Pseudomonas exotoxin fusion protein on human myeloma cells.
    Siegall CB; Chaudhary VK; FitzGerald DJ; Pastan I
    Proc Natl Acad Sci U S A; 1988 Dec; 85(24):9738-42. PubMed ID: 3264406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-4 regulation of murine lymphokine-activated killer activity in vitro. Effects on the IL-2-induced expansion, cytotoxicity, and phenotype of lymphokine-activated killer effectors.
    Mulé JJ; Krosnick JA; Rosenberg SA
    J Immunol; 1989 Jan; 142(2):726-33. PubMed ID: 2783444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective immunosuppression of activated T cells with the chimeric toxin IL-2-PE40. Inhibition of experimental autoimmune uveoretinitis.
    Roberge FG; Lorberboum-Galski H; Le Hoang P; de Smet M; Chan CC; Fitzgerald D; Pastan I
    J Immunol; 1989 Dec; 143(11):3498-502. PubMed ID: 2511243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells.
    Kasid A; Bell GI; Director EP
    J Immunol; 1988 Jul; 141(2):690-8. PubMed ID: 3133414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac allograft survival in mice treated with IL-2-PE40.
    Lorberboum-Galski H; Barrett LV; Kirkman RL; Ogata M; Willingham MC; FitzGerald DJ; Pastan I
    Proc Natl Acad Sci U S A; 1989 Feb; 86(3):1008-12. PubMed ID: 2644640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant anti-erbB2 immunotoxins containing Pseudomonas exotoxin.
    Batra JK; Kasprzyk PG; Bird RE; Pastan I; King CR
    Proc Natl Acad Sci U S A; 1992 Jul; 89(13):5867-71. PubMed ID: 1352878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Tac(Fv)-PE40, a single chain antibody Pseudomonas fusion protein directed at interleukin 2 receptor bearing cells.
    Batra JK; FitzGerald D; Gately M; Chaudhary VK; Pastan I
    J Biol Chem; 1990 Sep; 265(25):15198-202. PubMed ID: 2118522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of interleukin-6-enhanced lymphokine-activated killer cell function.
    Iho S; Shau HY; Golub SH
    Cell Immunol; 1991 Jun; 135(1):66-77. PubMed ID: 2018984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 2 pseudomonas exotoxin (IL2-PE66(4)Glu) chimeric protein kills B cells from patients with Myasthenia gravis.
    Steinberger I; Brenner T; Lorberboum-Galski H
    Cell Immunol; 1996 Apr; 169(1):55-61. PubMed ID: 8612294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An improved circularly permuted interleukin 4-toxin is highly cytotoxic to human renal cell carcinoma cells. Introduction of gamma c chain in RCC cells does not improve sensitivity.
    Puri RK; Leland P; Obiri NI; Husain SR; Mule J; Pastan I; Kreitman RJ
    Cell Immunol; 1996 Jul; 171(1):80-6. PubMed ID: 8660841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.